{"id":254913,"date":"2020-05-15T01:56:30","date_gmt":"2020-05-15T05:56:30","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=254913"},"modified":"2020-05-15T01:56:30","modified_gmt":"2020-05-15T05:56:30","slug":"us-first-access-to-virus-vaccine-unacceptable-france","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/05\/15\/us-first-access-to-virus-vaccine-unacceptable-france\/","title":{"rendered":"US first access to virus vaccine unacceptable: France"},"content":{"rendered":"
\"\"<\/a>
British firm GlaxoSmithKline has partnered with Sanofi on a potential vaccine for the virus, which has claimed nearly 300,000 lives and infected over 4.36 million in 188 countries. (File Photo: Drew Hays\/Unsplash)<\/figcaption><\/figure>\n

PARIS<\/strong>\u00a0\u2013 A top French official on Thursday said it would be \u201cunacceptable\u201d for the US to be given priority access to a vaccine for the novel coronavirus.<\/p>\n

Deputy Finance Minister Agnes Pannier-Runacher\u2019s comments came a day after the head of French pharmaceutical giant Sanofi suggested the company may give any successful COVID-19 vaccine it develops to the US before other countries.<\/p>\n

In an interview with American media outlet Bloomberg News, Sanofi CEO Paul Hudson said the US had the \u201cright to the largest pre-order because it\u2019s invested in taking the risk.\u201d<\/p>\n

The US government expanded a partnership with Sanofi earlier this year and Hudson, who has been in the post since last year, said Washington expects to have first access to any successful vaccine.<\/p>\n

The French minister reached out to Sanofi after Hudson\u2019s statements drew much criticism from people associated with the country\u2019s health care system.<\/p>\n

\u201cFor us, it would be unacceptable for there to be privileged access to such and such a country for financial reasons,\u201d Pannier-Runacher said in an interview with Sud Radio.<\/p>\n

British firm GlaxoSmithKline has partnered with Sanofi on a potential vaccine for the virus, which has claimed nearly 300,000 lives and infected over 4.36 million in 188 countries.<\/p>\n

But clinical trials have yet to start and any resulting drug is unlikely to surface before the end of 2021.<\/p>\n

The partnership between the two companies is partially funded by the Biomedical Advanced Research and Development Authority, a division of the US Department of Health and Human Services.\u00a0(Anadolu)<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

PARIS\u00a0\u2013 A top French official on Thursday said it would be \u201cunacceptable\u201d for the US to be given priority access …<\/p>\n","protected":false},"author":44,"featured_media":248681,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,17],"tags":[],"class_list":["post-254913","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-w","mauthors-anadolu","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/254913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=254913"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/254913\/revisions"}],"predecessor-version":[{"id":254914,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/254913\/revisions\/254914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/248681"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=254913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=254913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=254913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}